Found: 16
Select item for more details and to access through your institution.
Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Amrubicin for treating elderly and poor-risk patients with small-cell lung cancer.
- Published in:
- International Journal of Clinical Oncology, 2010, v. 15, n. 5, p. 447, doi. 10.1007/s10147-010-0085-2
- By:
- Publication type:
- Article
Effect of gefitinib on warfarin antithrombotic activity.
- Published in:
- International Journal of Clinical Oncology, 2009, v. 14, n. 4, p. 332, doi. 10.1007/s10147-008-0871-2
- By:
- Publication type:
- Article
Prognostic Significance of MYH9 Expression in Resected Non-Small Cell Lung Cancer.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0121460
- By:
- Publication type:
- Article
Clinicopathological Significance of S100A14 Expression in Lung Adenocarcinoma.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 594, doi. 10.1159/000478100
- By:
- Publication type:
- Article
Evaluation of Amrubicin as a Third or Later Line of Chemotherapy for Advanced Non-Small Cell Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2013, v. 59, n. 2, p. 99, doi. 10.1159/000354207
- By:
- Publication type:
- Article
Pemetrexed for Previously Treated Patients with Non-Small Cell Lung Cancer and Differences in Efficacy according to Thymidylate Synthase Expression.
- Published in:
- Chemotherapy (0009-3157), 2012, v. 58, n. 4, p. 313, doi. 10.1159/000343048
- By:
- Publication type:
- Article
Evaluation of gefitinib efficacy according to body surface area in patients with non-small cell lung cancer harboring an EGFR mutation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 939, doi. 10.1007/s00280-014-2570-1
- By:
- Publication type:
- Article
Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1529, doi. 10.1007/s00280-012-1858-2
- By:
- Publication type:
- Article
Diagnostic and Prognostic Significances of MUC5B and TTF-1 Expressions in Resected Non-Small Cell Lung Cancer.
- Published in:
- Scientific Reports, 2015, p. 8649, doi. 10.1038/srep08649
- By:
- Publication type:
- Article
Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer.
- Published in:
- Oncology, 2017, v. 92, n. 5, p. 283, doi. 10.1159/000458412
- By:
- Publication type:
- Article
Comparison of the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer according to the Type of Epidermal Growth Factor Receptor Mutation.
- Published in:
- Oncology, 2014, v. 87, n. 4, p. 215, doi. 10.1159/000362603
- By:
- Publication type:
- Article
Evaluation of concurrent chemoradiotherapy for locally advanced NSCLC according to EGFR mutation status.
- Published in:
- Oncology Letters, 2017, v. 14, n. 1, p. 885, doi. 10.3892/ol.2017.6231
- By:
- Publication type:
- Article
Successful chemotherapy with carboplatin and nab-paclitaxel for thymic large cell neuroendocrine carcinoma: A case report.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Circulating tumor cells as a prognostic factor in patients with small cell lung cancer.
- Published in:
- Oncology Letters, 2014, v. 7, n. 5, p. 1469, doi. 10.3892/ol.2014.1940
- By:
- Publication type:
- Article
Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markers.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0173886
- By:
- Publication type:
- Article